| Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19 BJ Meckiff, C Ramírez-Suástegui, V Fajardo, SJ Chee, A Kusnadi, ... Cell 183 (5), 1340-1353. e16, 2020 | 524 | 2020 |
| Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer J Clarke, B Panwar, A Madrigal, D Singh, R Gujar, O Wood, SJ Chee, ... Journal of Experimental Medicine 216 (9), 2128-2149, 2019 | 215 | 2019 |
| Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy S Eschweiler, J Clarke, C Ramírez-Suástegui, B Panwar, A Madrigal, ... Nature immunology 22 (8), 1052-1063, 2021 | 86 | 2021 |
| IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants YC Bartsch, S Eschweiler, A Leliavski, HB Lunding, S Wagt, J Petry, ... Journal of Allergy and Clinical Immunology 146 (3), 652-666. e11, 2020 | 61 | 2020 |
| Regulatory T cell frequencies are increased in preterm infants with clinical early-onset sepsis J Pagel, A Hartz, J Figge, C Gille, S Eschweiler, K Petersen, L Schreiter, ... Clinical & Experimental Immunology 185 (2), 219-227, 2016 | 47 | 2016 |
| Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs S Eschweiler, C Ramírez-Suástegui, Y Li, E King, L Chudley, J Thomas, ... Nature 605 (7911), 741-746, 2022 | 46 | 2022 |
| Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions A Epp, J Hobusch, YC Bartsch, J Petry, GM Lilienthal, CAM Koeleman, ... Journal of Allergy and Clinical Immunology 141 (1), 399-402. e8, 2018 | 45 | 2018 |
| CD4+ follicular helper-like T cells are key players in anti-tumor immunity D Singh, AP Ganesan, B Panwar, S Eschweiler, CJ Hanley, A Madrigal, ... bioRxiv, 2020.01. 08.898346, 2020 | 16 | 2020 |
| JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells S Eschweiler, A Wang, C Ramírez-Suástegui, A von Witzleben, Y Li, ... Cell reports 42 (2), 2023 | 6 | 2023 |
| Suppressive T Cell Populations and Methods of Cancer Immunotherapy P Vijayanand, C Ottensmeier, S Eschweiler, M Kronenberg US Patent App. 18/564,913, 2024 | | 2024 |
| Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy P Vijayanand, C Ottensmeier, S Eschweiler US Patent App. 17/625,226, 2022 | | 2022 |
| Development of Differentially Glycosylated IgG Antibodies S Eschweiler Universität zu Lübeck, 2017 | | 2017 |
